Logo image of ELI.BR

ELIA GROUP SA/NV (ELI.BR) Stock Fundamental Analysis

Europe - EBR:ELI - BE0003822393 - Common Stock

95.25 EUR
+1.1 (+1.17%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

4

ELI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 17 industry peers in the Electric Utilities industry. ELI has a medium profitability rating, but doesn't score so well on its financial health evaluation. ELI is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ELI was profitable.
ELI had a positive operating cash flow in the past year.
ELI had positive earnings in each of the past 5 years.
In multiple years ELI reported negative operating cash flow during the last 5 years.
ELI.BR Yearly Net Income VS EBIT VS OCF VS FCFELI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.76%, ELI is doing worse than 70.59% of the companies in the same industry.
The Return On Equity of ELI (6.51%) is worse than 82.35% of its industry peers.
ELI's Return On Invested Capital of 3.06% is on the low side compared to the rest of the industry. ELI is outperformed by 82.35% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ELI is significantly below the industry average of 8.35%.
The 3 year average ROIC (2.94%) for ELI is below the current ROIC(3.06%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.76%
ROE 6.51%
ROIC 3.06%
ROA(3y)1.67%
ROA(5y)1.64%
ROE(3y)6.79%
ROE(5y)6.49%
ROIC(3y)2.94%
ROIC(5y)2.96%
ELI.BR Yearly ROA, ROE, ROICELI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

Looking at the Profit Margin, with a value of 12.26%, ELI is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
ELI's Profit Margin has been stable in the last couple of years.
ELI has a Operating Margin of 25.74%. This is amongst the best in the industry. ELI outperforms 82.35% of its industry peers.
ELI's Operating Margin has been stable in the last couple of years.
ELI has a better Gross Margin (58.00%) than 82.35% of its industry peers.
In the last couple of years the Gross Margin of ELI has declined.
Industry RankSector Rank
OM 25.74%
PM (TTM) 12.26%
GM 58%
OM growth 3Y6.02%
OM growth 5Y-1.05%
PM growth 3Y1.12%
PM growth 5Y-0.28%
GM growth 3Y4.99%
GM growth 5Y-1.62%
ELI.BR Yearly Profit, Operating, Gross MarginsELI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELI is destroying value.
The number of shares outstanding for ELI remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ELI has more shares outstanding
Compared to 1 year ago, ELI has a worse debt to assets ratio.
ELI.BR Yearly Shares OutstandingELI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ELI.BR Yearly Total Debt VS Total AssetsELI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

ELI has an Altman-Z score of 0.77. This is a bad value and indicates that ELI is not financially healthy and even has some risk of bankruptcy.
ELI's Altman-Z score of 0.77 is on the low side compared to the rest of the industry. ELI is outperformed by 82.35% of its industry peers.
A Debt/Equity ratio of 1.96 is on the high side and indicates that ELI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.96, ELI is doing worse than 82.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Altman-Z 0.77
ROIC/WACC0.7
WACC4.35%
ELI.BR Yearly LT Debt VS Equity VS FCFELI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

ELI has a Current Ratio of 1.51. This is a normal value and indicates that ELI is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.51, ELI belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
ELI has a Quick Ratio of 1.43. This is a normal value and indicates that ELI is financially healthy and should not expect problems in meeting its short term obligations.
ELI's Quick ratio of 1.43 is amongst the best of the industry. ELI outperforms 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.43
ELI.BR Yearly Current Assets VS Current LiabilitesELI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.69% over the past year.
ELI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.91% yearly.
ELI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.50%.
The Revenue has been growing by 10.93% on average over the past years. This is quite good.
EPS 1Y (TTM)35.69%
EPS 3Y10.74%
EPS 5Y6.91%
EPS Q2Q%23.94%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y13.87%
Revenue growth 5Y10.93%
Sales Q2Q%9.34%

3.2 Future

Based on estimates for the next years, ELI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.09% on average per year.
Based on estimates for the next years, ELI will show a quite strong growth in Revenue. The Revenue will grow by 15.41% on average per year.
EPS Next Y4.48%
EPS Next 2Y9.78%
EPS Next 3Y11.43%
EPS Next 5Y14.09%
Revenue Next Year16.99%
Revenue Next 2Y18.77%
Revenue Next 3Y19.28%
Revenue Next 5Y15.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ELI.BR Yearly Revenue VS EstimatesELI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
ELI.BR Yearly EPS VS EstimatesELI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.46, the valuation of ELI can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of ELI is on the same level as its industry peers.
ELI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
The Price/Forward Earnings ratio is 16.06, which indicates a correct valuation of ELI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELI is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ELI to the average of the S&P500 Index (22.73), we can say ELI is valued slightly cheaper.
Industry RankSector Rank
PE 15.46
Fwd PE 16.06
ELI.BR Price Earnings VS Forward Price EarningsELI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ELI indicates a slightly more expensive valuation: ELI is more expensive than 70.59% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.41
ELI.BR Per share dataELI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.45
PEG (5Y)2.24
EPS Next 2Y9.78%
EPS Next 3Y11.43%

4

5. Dividend

5.1 Amount

ELI has a Yearly Dividend Yield of 1.54%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.31, ELI is paying slightly less dividend.
ELI's Dividend Yield is slightly below the S&P500 average, which is at 2.45.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

The dividend of ELI has a limited annual growth rate of 4.05%.
Dividend Growth(5Y)4.05%
Div Incr Years6
Div Non Decr Years6
ELI.BR Yearly Dividends per shareELI.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

25.37% of the earnings are spent on dividend by ELI. This is a low number and sustainable payout ratio.
The dividend of ELI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.37%
EPS Next 2Y9.78%
EPS Next 3Y11.43%
ELI.BR Yearly Income VS Free CF VS DividendELI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B
ELI.BR Dividend Payout.ELI.BR Dividend Payout, showing the Payout Ratio.ELI.BR Dividend Payout.PayoutRetained Earnings

ELIA GROUP SA/NV

EBR:ELI (9/12/2025, 7:00:00 PM)

95.25

+1.1 (+1.17%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)07-25 2025-07-25/bmo
Earnings (Next)11-28 2025-11-28
Inst Owners13.33%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap10.39B
Analysts80
Price Target114.17 (19.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly Dividend1.89
Dividend Growth(5Y)4.05%
DP25.37%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.52%
PT rev (3m)11.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.35%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)2.21%
Valuation
Industry RankSector Rank
PE 15.46
Fwd PE 16.06
P/S 2.5
P/FCF N/A
P/OCF 7.85
P/B 1.33
P/tB 2.16
EV/EBITDA 12.41
EPS(TTM)6.16
EY6.47%
EPS(NY)5.93
Fwd EY6.23%
FCF(TTM)-29.26
FCFYN/A
OCF(TTM)12.14
OCFY12.74%
SpS38.07
BVpS71.74
TBVpS44.01
PEG (NY)3.45
PEG (5Y)2.24
Profitability
Industry RankSector Rank
ROA 1.76%
ROE 6.51%
ROCE 4.33%
ROIC 3.06%
ROICexc 3.83%
ROICexgc 4.53%
OM 25.74%
PM (TTM) 12.26%
GM 58%
FCFM N/A
ROA(3y)1.67%
ROA(5y)1.64%
ROE(3y)6.79%
ROE(5y)6.49%
ROIC(3y)2.94%
ROIC(5y)2.96%
ROICexc(3y)3.56%
ROICexc(5y)3.54%
ROICexgc(3y)4.52%
ROICexgc(5y)4.55%
ROCE(3y)4.17%
ROCE(5y)4.19%
ROICexcg growth 3Y-6.4%
ROICexcg growth 5Y-9.25%
ROICexc growth 3Y-2.45%
ROICexc growth 5Y-6.12%
OM growth 3Y6.02%
OM growth 5Y-1.05%
PM growth 3Y1.12%
PM growth 5Y-0.28%
GM growth 3Y4.99%
GM growth 5Y-1.62%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Debt/EBITDA 8.88
Cap/Depr 683.43%
Cap/Sales 108.74%
Interest Coverage 3.18
Cash Conversion 76.55%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.43
Altman-Z 0.77
F-Score6
WACC4.35%
ROIC/WACC0.7
Cap/Depr(3y)492.24%
Cap/Depr(5y)397.61%
Cap/Sales(3y)75.93%
Cap/Sales(5y)64.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.69%
EPS 3Y10.74%
EPS 5Y6.91%
EPS Q2Q%23.94%
EPS Next Y4.48%
EPS Next 2Y9.78%
EPS Next 3Y11.43%
EPS Next 5Y14.09%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y13.87%
Revenue growth 5Y10.93%
Sales Q2Q%9.34%
Revenue Next Year16.99%
Revenue Next 2Y18.77%
Revenue Next 3Y19.28%
Revenue Next 5Y15.41%
EBIT growth 1Y56.72%
EBIT growth 3Y20.72%
EBIT growth 5Y9.77%
EBIT Next Year130.27%
EBIT Next 3Y51.9%
EBIT Next 5Y35.9%
FCF growth 1Y-84.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2501.18%
OCF growth 3Y-37.96%
OCF growth 5Y67.65%